Leonard Petrucelli, chair of the department of Neuroscience at the Mayo Clinic in Jacksonville, has received a 2013 Amyotrophic Lateral Sclerosis Research Program’s investigator-initiated award, which focuses on the discovery and validation of ALS biomarkers.
ALS (amyotrophic lateral sclerosis), also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Eventually, people with ALS lose the ability to initiate and control muscle movement, which often leads to total paralysis and death within two to five years of diagnosis. There is no cure and no life-prolonging treatments for the disease.
The Amyotrophic Lateral Sclerosis Research Program is a............
Via TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS